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Traditional Chinese medicine (TCM) treatments are often prescribed based on individuals’ pattern diagnoses. A systematic review
of randomized controlled trials in Chinese and English literatures on TCM pattern-based treatment for depression has therefore
been conducted. A total of 61 studies, 2504 subjects, and 27 TCM patterns were included. Due to the large variation of TCM
pattern among participants, we only analyzed the top four commonly studied TCM patterns: liver qi depression, liver depression and
spleen deficiency, dual deficiency of the heart, and spleen and liver depression and qi stagnation. We found that Xiaoyao decoction
was the most frequently used herbal formula for the treatment of liver qi depression and liver depression with spleen deficiency,
while Chaihu Shugan decoction was often used for liver depression and qi stagnation. Bai Shao (Paeonia lactiflora Pall.) and Chai
Hu (Bupleurum chinense DC.) were commonly used across different TCM patterns regardless of the prescribed Chinese herbal
formulas. The rationale underlying herb selection was seldom provided. Due to the limited number of studies on TCM pattern-
based treatment of depression and their low methodological quality, we are unable to draw any conclusion regarding which herbal
formulas have higher efficacy and which TCM patterns respond better to CHM.
1. Introduction
According to the Global Burden of Disease Study 2010, major
depressive disorder (MDD) was ranked the second leading
cause of years lived with disability, accounting for 8.2% of
all years lived with disability [1]. The World Mental Health
Survey Initiative showed that the average lifetime prevalence
for major depressive episode based on the Diagnostic and
Statistical Manual, Fourth Edition [2], was 14.6% in 10 high-
income countries and 11.1% in 8 low- tomiddle-income coun-
tries [3]. Pharmacotherapy is currently the most commonly
used treatment forMDDbecause of its reported effectiveness;
however, complaints such us nausea, headache, insomnia,
agitation, weight gain, daytime somnolence, and sexual dys-
function are common during the course of treatment, leading
to early termination in some patients. The use of psychother-
apy as an alternative is no better because of its time-intensive
nature, limited access to skilled providers, high cost, and
requirement of patients’ participation and motivation. Faced
with the limitations of the currently available treatments,
complementary and alternative medicine for depression is
very common. A national representative survey in the United
States found that 53.6% of people with depression reported
using some forms of complementary and alternative therapies
to treat depression during the past 12 months [4].
Chinese herbal medicine (CHM) is one of the oldest
medical treatments in the world and it is a common form of
complementary and alternative medicine therapy for MDD
[5, 6]. Previous studies have been conducted to examine
the efficacy of CHM for depression [7–14]; however, limited
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information is available on pattern-based CHM treatment.
According to the traditional Chinese medicine (TCM) the-
ory, eight major parameters, yin and yang, external and
internal, hot and cold, and excess and deficiency, are used
to describe the patterns of bodily disharmony. Additional
systems, such as qi, blood, and body fluid differentiation and
zang fu (organ) differentiation are also used [15]. In terms
of the TCM theory, the onset of depression is often due
to “damages” by extreme emotions. Liver qi is first affected,
followed by disharmony of the qi mechanism of the five
viscera, particularly liver, spleen, and heart, resulting in a loss
of regulation of the qi and blood. The liver depression may
repress the spleen and lead to consumption and damage of
the heart qi. If heart loses its nourishment and the restfulness
to heart shen (spirit) occurs, it will lead to unstable and
depressed mood. When qi depression is prolonged, it will
accumulate and transform into fire [16, 17].
TCM pattern differentiation is a diagnostic conclusion
of the pathological changes of a disease state based on
an individual’s symptoms, physical signs, pulse form, and
tongue appearance. Although it is believed that pattern-
based TCM treatment will provide better efficacy, previous
studies regarding the additional benefits of TCM pattern
differentiation are scarce. One randomized controlled trial
(RCT) found that the therapeutic effect of Chinese herbal
treatment according to TCM pattern was more sustainable
than a standard formula in treating irritable bowel syndrome
[18]. It has also been reported in rheumatoid arthritic patients
that TCM pattern diagnoses can guide the use of Western
medicine [19]. To the best of our knowledge, no systematic
review has been conducted on pattern-basedCHM treatment
for depression. Given the high prevalence of depression and
its frequent presentation toTCMpractitioners, it is important
to review the current application of pattern differentiation
in CHM treatment for depression. The objectives of this
paper were (1) to summarize the commonly diagnosed TCM
patterns in patients with depression and (2) to find out
the current practice of pattern-based CHM treatment for
depression.
2. Materials and Methods
The present study was part of our systematic review on
Chinese herbal medicine for depression [11, 20]. Two
researchers (Ka-Yan Ng and Yee-Man Yu) independently
searched nine Chinese language databases (China Jour-
nals Full-text Database, China Proceedings of Conference
Full-text Database, Chinese Biomedical Literature Database,
ChinaDoctorDissertations Full-text Database, ChinaMaster
Theses Full-text Database, Chinese Science and Technol-
ogy Documents Database, Chinese Dissertation Document
Bibliography Database, Taiwan Electronic Periodical Ser-
vices, and WanFang Database) and seven English language
databases (MEDLINE, EMBASE, Cochrane Central Register
of Controlled Trials, Cumulative Index to Nursing and Allied
Health Literature, Allied and Complementary Medicine,
PsycINFO, and ProQuest Dissertations and Theses A&I)
using the grouped terms “depression∗ or depressive∗ or
dysthymia∗ or mood disorder∗ or “affective disorder∗” or
“affective symptoms” or MDD” and “Chinese herb∗ or herbal
medicine∗ or traditional Chinesemedicine∗ orTCMorChai-
Hu-Shu-Gan-San or ChaiHuShuGan∗ or Xiao-Yao-San or
XiaoYao∗ or Ban-Xia-Hou-Pu-Tang or BanXiaHouPu∗ or
Gan-Mai-Da-Zao-Tang or GanMaiDaZao∗ or Gui-Pi-Tang
or GuiPi∗ or Wen-Dan-Tang or WenDan or Yue-Ju-Wan or
Yue-Ju” and the equivalent Chinese terms. We imposed no
language restriction. We also checked the reference lists of
the included papers and previous systematic reviews [7–14]
for relevant articles.
2.1. Selection Criteria. Studies included in this review were
RCTs that described TCMpatterns of depressed subjects who
received CHM treatment for depression. In order to obtain
a full coverage of the topic, we had not set any specification
for outcomemeasure and study quality. In addition, to derive
a general picture of TCM pattern utilization, studies were
excluded if they (1) had less than 30 subjects; (2) examined
male or female only; (3) focused on subjects aged below 18
or above 70 years; (4) focused on a particular life transition
period or a specific TCM pattern; (5) had no statistical
information regarding the frequency of individual TCM
pattern; or (6) were duplicated publications.
2.2. Data Extraction Process. Any disagreement about the
eligibility of a study was resolved by discussion between
the two researchers who independently selected the relevant
publications and by consultation with the senior authors
(Wing-Fai Yeung and Ka-Fai Chung). One author extracted
the data (Ka-YanNg) and the other (Yee-ManYu) checked the
extracted data. For each study, the following variables were
extracted: study design, sample size, mode of recruitment,
sampling and diagnostic procedure, inclusion and exclusion
criteria, and participants’ characteristics including age, gen-
der, and duration of depression. TCM patterns, treatment
principles, treatment regimen and outcome of TCM treat-
ments were obtained. All Chinese to English translations
were deduced primarily from theWorld Health Organization
(WHO) International Standard Terminologies on Traditional
Medicine in the Western Pacific Region [21] and additionally
from Traditional Chinese Internal Medicine [22], a commonly
used English-language TCM textbook in China.
2.3. Study Quality Assessment. We assessed the methodolog-
ical quality using the Jadad scale [23]. Points are awarded if
the study is described as randomized, 1 point; has appropriate
randomization method, 1 point; is described as double-blind,
1 point; uses appropriate blinding method, 1 point; or has
description of withdrawals and dropouts, 1 point. A Jadad
scale score ≥3 represents better quality trials.
2.4. Statistical Analysis. SPSS version 20.0 was used for
statistical analysis. Data were summarized using mean (SD)
and 95% confidence intervals (CIs).
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2724 records identified through Chinese database
searching
2256 records identified through English database
searching
4168 records after duplicates removed
574 full-text articles assessed for eligibility
296 studies examined Chinese herbal medicine for 
depression
Identical citations: 929
Excluded (n = 278)
∙ Case series: 60
∙ Invalid control: 54
∙ Not on Chinese herbal 
medicine: 33
∙ No randomization: 32
∙ Not on depression: 22
∙ Identical paper: 21 
∙ Duplicated publication: 18
∙ Discussion papers: 16
∙ Failed to retrieve: 13
∙ Review papers: 5
∙ Animal study: 4
117 records identified from previous
reviews 
Irrelevant papers: 3594
61 studies examined TCM intervention for
depression with TCM pattern diagnosis 
42 studies analyzed
Excluded (n = 235)
∙ No TCM pattern diagnosis: 
191
∙ Having no statistical 
information regarding the 
frequency of individual TCM 
pattern: 43
∙ Only studied male or 
female patients: 1l
Figure 1: Study selection flowchart.
3. Results
The search yielded 5097 potential titles for review, of which
929 were duplicated records and 3594 were excluded for
reasons of irrelevance. The full text of 574 was retrieved
for detailed assessment, of which 278 were excluded for
various reasons (Figure 1). Of the 296 studies on CHM for
depression, 61 of them examined pattern-based treatment.
A total of 27 different TCM patterns were identified in
the 61 studies. We analyzed the most commonly studied
TCM patterns: liver qi depression, liver depression and spleen
deficiency, dual deficiency of the heart and spleen, and liver
depression and qi stagnation and liver-kidney yin deficiency.
These four commonly studied TCM patterns were described
in 42 of the 61 studies (68.9%) and involved 1762 subjects
accounting for 70.4% of the total 2504 subjects (Table 1).
Eighteen of the 42 studies examined CHM alone and the
other 24 studies examined CHM plus antidepressants [24–
65]. The 1762 participants had a mean age of 40.7 years, of
which 59.0% were female. The participants were suffering
4 Evidence-Based Complementary and Alternative Medicine
Table 1: The most common TCM patterns diagnosed in people with depression.
TCM pattern Chinese name Number of subjects diagnosed withthe TCM pattern (%) (total𝑁 = 1762)
Number of studies that examined the
TCM pattern (%) (total𝑁 = 42)a
Liver qi depression 肝氣鬱結 797 (45.2%) 19 (45.2%)
Liver depression and spleen deficiency 肝鬱脾虛 425 (24.1%) 13 (31.0%)
Dual deficiency of the heart and spleen 心脾兩虛 315 (17.9%) 9 (21.4%)
Liver depression and qi stagnation 肝鬱氣滯 225 (12.8%) 8 (19.0%)
aSix studies examined more than one TCM pattern.
from depression unspecified in 33 of the 42 studies, six
studies on poststroke depression and three on depression
comorbid with diabetes. The diagnosis of depression was
based on 17-item or 24-item Hamilton Depression Rating
Scale (HAMD
17/24
) in 36 studies, the Chinese Classification
of Mental Disorder Second/Second-revised/Third Edition
(CCMD-2/2-R/3) in 35 studies, Zung Self-rating Depression
Scale (SDS) in seven studies, and one study each using DSM-
IV, Clinical Global Impression Scale (CGI), and International
Classification of Diseases Version 10 (ICD-10). The response
to intervention was assessed by the HAMD17/24 in 34 studies
and by effective rate in 33 studies.
The criteria used for TCM pattern diagnosis were
reported in 27 of the 42 studies. The criteria were based on
the TCM Syndrome Diagnostic Standard (𝑁 = 7), New
Guidelines for TCM Clinical Research (𝑁 = 3), TCM
Diagnostic Standard for Depression (𝑁 = 2), Chinese
Professional Association of Integrative Medicine Diagnostic
Criteria for Mental Disorders, Version 1991/2001 (𝑁 = 3),
Chinese Classification and Diagnostic Criteria of Mental
Disorders (𝑁 = 1), and TCM textbooks (𝑁 = 13). However,
none of the studies described other details of the diagnostic
procedure and the background of practitioners whomade the
pattern diagnosis.
3.1. Methodological Quality. Twenty-three (54.8%) of the 42
studies were described as randomized but the randomization
method, blinding, and dropouts were not presented; hence,
these 23 studies only had a Jadad scale score of one. Seventeen
studies (40.5%) had a Jadad scale score of two, and only two
studies (4.8%) obtained a Jadad scale score of four.
3.2. Pattern-Based CHM Treatment
3.2.1. Liver qi Depression. According to the TCM theory,
liver qi depression is an impairment of the liver function,
obstructing free movement of qi and resulting in stagnation
of qi in liver [21]. Nineteen studies examined CHM treat-
ment in patients with liver qi depression. Seven studies used
CHM alone and 12 used CHM-antidepressant combination.
Xiaoyao decoction was investigated in 13 (68.4%) of the 19
studies, while other CHM formulas were studied in only one
to two studies. Seventeen studies reported the ingredients of
the CHM formulas for the treatment of liver qi depression.
Chai Hu (Bupleurum chinense DC.) was the most commonly
used herb, followed by Bai Shao (Paeonia lactiflora Pall.),
Dang Gui (Angelica sinensis (Oliv.) Diels), Fu Ling (Poria
Cocos (Schw)Wolf.), and Bai Zhu (Atractylodes macrocephala
Koidz.). These five herbs were chosen for treating liver qi
depression inmore thanhalf of the 17 studies that had reported
the CHM ingredients (Table 2). The mean effective rate of
Xiaoyao decoction for the treatment of liver qi depressionwas
84.7% and the mean HAMD change score was 19.1 (Table 3);
for Xiaoyao decoction-antidepressant combination for liver
qi depression, it was 86.0% and 19.1, respectively (Table 4).
Tables 3 and 4 present the overall efficacy of pattern-based
CHM monotherapy and CHM-antidepressant combination
for liver qi depression.
3.2.2. Liver Depression and Spleen Deficiency. According to
the TCM theory, liver depression and spleen deficiency is a
pathological change in which the transporting and trans-
forming function of the spleen is affected by depressed liver
qi, leading to spleen deficiency [21]. Of the 13 studies on
liver depression and spleen deficiency, three studies examined
CHM alone and 10 investigated CHM-antidepressant com-
bination. The most frequently used CHM formula was also
Xiaoyao decoction, whichwas used in 9 of the 13 studies. Nine
of the 13 studies provided ingredients of the CHM formulas.
The commonly used single herbs for the treatment of liver
depression and spleen deficiency were Bai Shao (Paeonia
lactiflora Pall.), Fu Ling (Poria Cocos (Schw) Wolf.), Chai
Hu (Bupleurum chinense DC.), Zhi Ke (Citrus × aurantium
L.), Dang Gui (Angelica sinensis (Oliv.) Diels), and Bai Zhu
(Atractylodes macrocephalaKoidz.) (Table 2). Only one study
was conducted on Xiaoyao decoction monotherapy for liver
depression and spleen deficiency, and the HAMD change
score was 7.3 (Table 3). The mean effective rate of Xiaoyao
decoction-antidepressant combination for liver depression
and spleen deficiencywas 86.0% and themeanHAMDchange
score was 20.1 (Table 4). Tables 3 and 4 show the overall
efficacy of pattern-based CHM monotherapy and CHM-
antidepressant combination for liver depression and spleen
deficiency.
3.2.3. DualDeficiency of theHeart and Spleen. Dual deficiency
of the heart and spleen is a condition in which both heart
blood and spleen qi are deficient, leading to disordered
heart function and an impairment of the transporting and
transforming function of spleen [21]. There was significant
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variation in the TCM pattern-based CHM treatment for dual
deficiency of the heart and spleen. Of the 10 relevant studies,
seven different CHM formulas were used. Guipi Tang and
NingcaoWangyou Tang were each used in two studies, while
other CHM formulas were only examined once. The fre-
quently used single herbs for dual deficiency of the heart and
spleen were Gan Cao (Glycyrrhiza uralensis Fisch.), Bai Shao
(Paeonia lactiflora Pall.), Chai Hu (Bupleurum chinenseDC.),
Fu Ling (Poria Cocos (Schw) Wolf.), Bo Zi Ren (Platyclatus
orientalis (L.) Franco), Da Zao (Ziziphus jujuaMill.), and Yu
Jin (Curcuma wenyujin Y. H. Chen & C. Lin) (Table 2). The
mean effective rate of CHMmonotherapy for dual deficiency
of the heart and spleen was 91.5% and the mean HAMD
change score was 10.8 (Table 3); for CHM-antidepressant
combination, it was 77.0% and 11.4, respectively (Table 4).
3.2.4. Liver Depression and qi Stagnation. Liver depression
and qi stagnation is a pathological change in which liver is
depressed, leading to impeded circulation of qi and stagna-
tion of qi movement [21]. The most frequently used CHM
formula for liver depression and qi stagnation was Chaihu
Shugan decoction (Table 3).The commonly used single herbs
were Bai Shao (Paeonia lactiflora Pall.), Yu Jin (Curcuma
wenyujinY. H. Chen&C. Lin), Chai Hu (Bupleurum chinense
DC.), Chuan Xiong (Ligusticum striatum DC.), Xiang Fu
(Cyperus rotundus L.), Zhi Ke (Citrus × aurantium L.),
Xiang Fu (Cyperus rotundus L.), and He Huan Pi (Albizia
julibrissinDurazz.) (Table 2).Themean effective rate of CHM
monotherapy for liver depression and qi stagnationwas 90.4%
and the mean HDRS change score was 17.5 (Table 3); for
CHM-antidepressant combination, it was 80.0% and 15.0,
respectively (Table 4).
4. Discussion
This study is the first systematic review of English and
Chinese literature, involving 61 studies and 2504 subjects
on the classification and treatment of depression using the
TCM diagnostic system. We found that the TCM pattern
diagnoses for depression were diverse. Among 27 differ-
ent TCM patterns identified, liver qi depression was the
most commonly diagnosed TCM pattern in people with
depression, followed by liver depression and spleen deficiency,
dual deficiency of the heart and spleen, and liver depression
and qi stagnation. With regard to CHM treatment, Xiaoyao
decoction was the most frequently used herbal formula for
the treatment of liver qi depression and liver depression and
spleen deficiency, while Chaihu Shugan decoction was often
used for liver depression and qi stagnation. For dual deficiency
of the heart and spleen, no single formula could be regarded
as commonly used across TCM practitioners. The results
suggest that TCMpractitionersmay bemore consistent in the
treatment of depression involving liver depression than other
patterns.The abundance of low-quality studies highlights that
knowledge and experience in conducting high-quality RCTs
may be limited. It further suggests that institutional review
boards and publishing journals should play an active role in
monitoring the standards of clinical trials.
The present paper found that Bai Shao (Paeonia lacti-
flora Pall.), which has a function of nourishing the blood
and emolliating the liver, and Chai Hu (Bupleurum chi-
nense DC.), which can sooth the liver, were commonly
used to treat depression regardless of the TCM pattern.
Animal studies have found that extract from Bai Shao
produces antidepressant effects in chronic unpredictable
stress-induced depression model in mice and rats [66]. The
antidepressant effects are likely mediated by inhibition of the
monoamine oxidase activity and oxidative stress, upregula-
tion of neurotrophins, and modulation of the function of the
hypothalamic-pituitary-adrenal axis [66]. Pharmacological
studies of Chai Hu have shown that it has hepatoprotective,
anti-inflammatory, antipyretic, analgesic, and immunomod-
ulatory effects [67–70]; however, its antidepressant effects
remain unclear. According to a TCM textbook, Chai Hu is
a “Sovereign” herb in Xiaoyao decoction and Chaihu Shugan
decoction [69]. The “Sovereign” herb is used for treating the
principal diseases based on the TCM theory; the “Minister”
herb has synergistic effects with “Sovereign” herbs and helps
to alleviate other accompanying symptoms; the “Assistant”
herb is for enhancing the therapeutic effects and modulating
the adverse effects of “Sovereign” and “Minister” herbs, while
the “Courier” herb is used for harmonizing the actions of
the others [66].Therefore, some of the commonly used herbs
identified in this review may not primarily be targeted at
depression; instead, they indirectly alleviate depression by
enhancing or harmonizing the actions of other herbs. In view
of the common use of ChaiHu in the treatment of depression,
further studies on its antidepressant effects are warranted.
Xiang Fu (Cyperus rotundus L.) and He Huan Pi (Albizia
julibrissin Durazz.) were specifically used for liver depression
and qi stagnation, and Bo Zi Ren (Platyclatus orientalis (L.)
Franco), which has a function of nourishing the heart and
tranquilizing shen, was specific for dual deficiency of the
heart and spleen. Yu Jin (Curcuma wenyujin Y. H. Chen
& C. Lin) was commonly used for liver depression and qi
stagnation and dual deficiency of the heart and spleen, Fu
Ling (Poria Cocos (Schw) Wolf.) for liver qi depression, liver
depression and spleen deficiency, and dual deficiency of the
heart and spleen, and Dang Gui (Angelica sinensis (Oliv.)
Diels) and Bai Zhu (Atractylodes macrocephala Koidz.) for
liver qi depression and liver depression and spleen deficiency.
Since three of the four commonly diagnosed TCM patterns
in people with depression involve liver depression and two
involve spleen deficiency, the prescription of Chinese herbs
for different TCM patterns are inevitably overlapping. A lack
of consistency across TCM practitioners in their selection of
herbal formulas and pattern-based prescription of individual
herbs may also lead to variation in CHM treatment [70].
Considering the limited number of studies available, further
research on pattern-based CHM treatment for depression is
warranted.
Due to the studies’ variation in study design and inade-
quate methodological quality, it is difficult to conclude which
herbal formulas have higher efficacy andwhichTCMpatterns
respond better to CHM. As a whole, there is no evidence
to suggest CHM-antidepressant combination has higher
efficacy than CHM monotherapy for depression. We found
10 Evidence-Based Complementary and Alternative Medicine
that the effective rate was generally high for pattern-based
treatment in liver qi depression and was similar between
CHM monotherapy and CHM-antidepressant combination.
For liver depression and spleen deficiency, the efficacy of
CHM monotherapy and CHM-antidepressant combination
was similar in terms of effective rate, but it was lower
with CHM monotherapy in terms of mean HAMD change
score (9.7 versus 20.1 for CHM-antidepressants combina-
tion). For dual deficiency of the heart and spleen, the efficacy
of pattern-based CHM treatment was relatively weaker,
especially CHM-antidepressant combination, which had a
mean effective rate of 77.0% and mean HAMD change
score of 11.4. For liver depression and qi stagnation, the
efficacy of CHM monotherapy and CHM-antidepressant
combination was similar, except for a relatively low mean
effective rate of CHM-antidepressant combination (80.9%
versus 90.4% for CHMmonotherapy). It is clear that further
studies with better methodological quality are needed to
delineate the efficacy of pattern-based CHM treatment in
depression.
There are some methodologic limitations of the study.
First, there is no “gold standard” in the classification of TCM
patterns, and the criteria for each pattern might be different
between researchers. Future studies using both Western and
Chinese medicine systems in diagnosis and severity assess-
mentmay facilitateWestern-Chinesemedicine integration in
the understanding and treatment of depression. Although we
reported the pattern diagnosis by the authors, the procedure
and quality of the diagnostic process was uncertain. Such
uncertainties would inevitably lead to discrepancies in the
selection of herbs in treatment. Although a large number
of studies were reviewed, this paper only summarized the
effective rate and HAMD change score based on RCTs; meta-
analysis was not possible due to difference in study design and
low methodological quality of the studies.
Despite the limitations, the present study, for the
first time, systematically and comprehensively summarized
important data on pattern-based CHM treatment for depres-
sion. Our data should be useful for both clinical practice
and future research. More high quality studies incorporating
TCM pattern differentiation and treatment principle are
needed to examine the efficacy of TCM treatments and the
additional benefit of pattern differentiation.
5. Conclusion
We found that liver qi depression, liver depression and spleen
deficiency, dual deficiency of the heart and spleen, and liver
depression and qi stagnationwere themost commonly studied
TCM patterns in people with depression. In addition, Bai
Shao (Paeonia lactiflora Pall.) and Chai Hu (Bupleurum
chinense DC.) were commonly used across different TCM
patterns regardless of the prescribed Chinese herbal formu-
las. Due to the limited number of studies on TCM pattern-
based treatment of depression and their low methodological
quality, we are unable to draw any conclusion regarding
which herbal formulas have higher efficacy and which TCM
patterns respond better to CHM.
Conflict of Interests
The authors have no conflict of interests to report.
Acknowledgment
The study was supported by the Chinese Medicine Research
Fund of the Hospital Authority of Hong Kong (Project no.
HACMR001).
References
[1] A. J. Ferrari, F. J. Charlson, R. E. Norman et al., “Burden of
depressive disorders by country, sex, age, and year: findings
from the global burden of disease study 2010,” PLoS Medicine,
vol. 10, no. 11, Article ID e1001547, 2013.
[2] American Psychiatric Association, Diagnostic and Statistical
Manual of Mental Disorders, American Psychiatric Association,
Washington, DC, USA, 4th edition, 1994.
[3] E. Bromet, L. H. Andrade, I. Hwang et al., “Cross-national
epidemiology of DSM-IV major depressive episode,” BMC
Medicine, vol. 9, no. 1, article 90, 2011.
[4] R. C. Kessler, J. Soukup, R. B. Davis et al., “The use of
complementary and alternative therapies to treat anxiety and
depression in the United States,” The American Journal of
Psychiatry, vol. 158, no. 2, pp. 289–294, 2001.
[5] M. C. Hsu, D. Creedy,W.Moyle, L. Venturato, S. L. Tsay, andW.
C. Ouyang, “Use of complementary and alternative medicine
among adult patients for depression in Taiwan,” Journal of
Affective Disorders, vol. 111, no. 2-3, pp. 360–365, 2008.
[6] N. A. Qureshi and A. Mohammed, “Mood disorders and
complementary and alternative medicine: a literature review,”
Neuropsychiatric Disease and Treatment, vol. 9, pp. 639–658,
2013.
[7] F. Qin, X.-A. Wu, Y. Tang, Q. Huang, Z.-J. Zhang, and J.-H.
Yuan, “Meta-analysis of randomized controlled trials to assess
the effectiveness and safety of free and easy Wanderer plus,
a polyherbal preparation for depressive disorders,” Journal of
Psychiatric Research, vol. 45, no. 11, pp. 1518–1524, 2011.
[8] H. Zhao, X. Wan, and J.-X. Chen, “A mini review of traditional
Chinesemedicine for the treatment of depression inChina,”The
American Journal of ChineseMedicine, vol. 37, no. 2, pp. 207–213,
2009.
[9] L. Butler and K. Pilkington, “Chinese herbal medicine and
depression: the research evidence,” Evidence-Based Comple-
mentary and Alternative Medicine, vol. 2013, Article ID 739716,
14 pages, 2013.
[10] M. J. Kou and J. X. Chen, “Integrated traditional and Western
medicine for treatment of depression based on syndrome
differentiation: a meta-analysis of randomized controlled trials
based on the Hamilton depression scale,” Journal of Traditional
Chinese Medicine, vol. 32, no. 1, pp. 1–5, 2012.
[11] W.-F. Yeung, K.-F. Chung, K.-Y. Ng, Y.-M. Yu, E. Tat-Chi Ziea,
and B. Fung-Leung Ng, “A meta-analysis of the efficacy and
safety of traditional Chinese medicine formula Ganmai Dazao
decoction for depression,” Journal of Ethnopharmacology, vol.
153, no. 2, pp. 309–317, 2014.
[12] X. K. Qing, P. Li, M. Han et al., “Systematic review of randomize
controlled trials of Xiaoyao powder in treatment of depression,”
Journal of Traditional Chinese Medicine, vol. 51, no. 6, pp. 500–
505, 2010.
Evidence-Based Complementary and Alternative Medicine 11
[13] Y. Wang, R. Fan, and X. Huang, “Meta-analysis of the clinical
effectiveness of traditional Chinese medicine formula Chaihu-
Shugan-San in depression,” Journal of Ethnopharmacology, vol.
141, no. 2, pp. 571–577, 2012.
[14] J. Liu, Y. Zhang, M. Han, Z. Liu, J. Wang, and Q. He, “Chinese
herbal formula Xiao Yao San for treatment of depression: a
systematic review of randomized controlled trials,” Evidence-
Based Complementary and Alternative Medicine, vol. 2012,
Article ID 931636, 13 pages, 2012.
[15] W. Yang, F. Meng, and Y. Jiang, Diagnostics of Traditional
Chinese Medicine, Academy Press, Beijing, China, 1998.
[16] R. N. Schnyer and B. Flaws, Curing Depression Naturally with
Chinese Medicine, Blue Poppy Press, Boulder, Colo, USA, 1998.
[17] Y. Wang, M. Li, X. Dai, and G. Fan, Internal Chinese Medicine,
Shanghai Scientific and Technological Documentation Publish-
ing House, Shanghai, China, 1997.
[18] A. Bensoussan, N. J. Talley, M. Hing, R. Menzies, A. Guo, and
M. Ngu, “Treatment of irritable bowel syndrome with Chinese
herbal medicine: a randomized controlled trial,” Journal of the
American Medical Association, vol. 280, no. 18, pp. 1585–1589,
1998.
[19] Q.-L. Zha, Y.-T.He, and J.-P. Yu, “Correlations between diagnos-
tic information and therapeutic efficacy in rheumatoid arthritis
analyzedwith decision treemodel,”Chinese Journal of Integrated
Traditional and Western Medicine, vol. 26, no. 10, pp. 871–876,
2006.
[20] W.-F. Yeung, K.-F. Chung, K.-Y. Ng, Y.-M. Yu, E. T.-C. Ziea,
and B. F.-L. Ng, “A systematic review on the efficacy, safety and
types of Chinese herbal medicine for depression,” Journal of
Psychiatric Research, vol. 57, no. 7, pp. 165–175, 2014.
[21] World Health Organization, WHO International Standard Ter-
minologies onTraditionalMedicine in theWestern Pacific Region,
World Health Organization, Western Pacific Region, 2007.
[22] B. Peng and J. Xie, Traditional Chinese Internal Medicine,
People’sMedical PublishingHouse, Beijing, China, 2nd edition,
2007.
[23] A. R. Jadad, R. A. Moore, D. Carroll et al., “Assessing the quality
of reports of randomized clinical trials: is blinding necessary?”
Controlled Clinical Trials, vol. 17, no. 1, pp. 1–12, 1996.
[24] B. Lin and J. Xia, “Clinical observation on modified chaihu
shugan san on depression,” Journal of New Chinese Medicine,
vol. 4, no. 8, pp. 36–37, 2011 (Chinese).
[25] B. Y. Yan, “Clinical observation on integrated traditional Chi-
nese andWestern medicine in treating depression,”Guangming
Journal of Chinese Medicine, vol. 24, no. 9, pp. 1761–1762, 2009
(Chinese).
[26] B. Zhou and H. Yan, “Efficacy of integrated traditional Chinese
andWestern medicine on 30 cases of depression caused by liver
stagnation and spleen deficiency,” Tianjin Journal of Traditional
Chinese Medicine, vol. 29, no. 4, pp. 329–331, 2012 (Chinese).
[27] D. L. Zhaou, J. Xia, J. Li, and Y. Y. Ma, “Clinical observation on
treatment of depressive disorder by fluvoxamine combinedwith
Xiaoyao pills,” Sichuan Mental Health, vol. 25, no. 2, pp. 97–99,
2012 (Chinese).
[28] E. P. Xu, “Treatment of danzhi xiaoyao san combining fluoxetine
in treating 70 cases of post-stroke depression,” Research of
Chinese Medicine, vol. 19, no. 4, pp. 31–32, 2006 (Chinese).
[29] F.Mou andX. Y. Zhou, “Clinical observation of Shexiang baoxin
pills in treating 129 cases of depression,” Chinese Traditional
Patent Medicine, vol. 26, no. s1, pp. 69–70, 2004 (Chinese).
[30] F. Zhang, “Xiaoyao San treatment of depression 60 cases,”
Journal of Practical Traditional Chinese Internal Medicine, vol.
26, no. 6, pp. 37–38, 2012 (Chinese).
[31] G.-H. Yu, S.-C. Liang, and Q.-Z. Sun, “Study on modified
xiaoyao decoction combining clomipamine in treating depres-
sion,” Chinese Journal of Integrated Traditional and Chinese
Medicine, vol. 27, no. 4, pp. 318–320, 2007 (Chinese).
[32] H. D. Zhang and H. Su, “Clinical comparative study of paroxe-
tine combined with Xiaoyao pill of depression,”Modern Journal
of Integrated Traditional Chinese and Western Medicine, vol. 18,
no. 33, pp. 4060–4063, 2009 (Chinese).
[33] H. Li, S. Xu, B. Li et al., “Xiaoyao San combining fluoxetine
in treating 41 cases of depression caused by liver depression
and spleen deficiency,” Shaanxi Journal of Traditional Chinese
Medicine, vol. 30, no. 1, pp. 49–50, 2009 (Chinese).
[34] H. M. Wang and Q. H. Dong, “Clinical observation of anseng
jieyu fang in treating depression in patients with type 2
diabetes,” Journal of New Chinese Medicine, vol. 44, no. 10, pp.
72–73, 2012 (Chinese).
[35] H. Y. Wang, B. J. Zhang, X. Liu, and Y. D. Tao, “Clinical obser-
vation on treatment of first-episode depression by duloxetine
combined with Xiaoyaowan mixture,” Sichuan Mental Health,
vol. 26, no. 1, pp. 32–34, 2013 (Chinese).
[36] H. Zhang and S. H. Li, “Kaiyu quhuo tang combining fluoxetine
capsule in treating 44 cases of depression,” Shaanxi Journal of
Traaditional Chinese Medicine, vol. 33, no. 6, pp. 674–675, 2012
(Chinese).
[37] J. Huo, H. P. Fu, J. Yang et al., “The clinical research of depressive
disorder treated in dan-zhi decoction for ease combined fluox-
etine,” Journal of Henan University of Chinese Medicine, vol. 23,
no. 136, pp. 38–39, 2010 (Chinese).
[38] J. P. Xian, Q. Zhou, and X. D. Li, “Clinical observation of
modified xiaoyao san combining paroxetine in treating depres-
sion,” Contemporary Medicine, vol. 16, no. 13, pp. 154–155, 2010
(Chinese).
[39] J. R. Zhang, “Effect of xiao chaihu tang in treating 40 cases of
depression,” Beijing Journal of TCM, vol. 22, no. 5, pp. 38–39,
2003 (Chinese).
[40] J. Y. Zheng, “Observation on the efficacy of Ganmai Dazao
Tang combining Suan Zaoren Tang in treating post-stroke
depression,” Beijing Journal of Traditional ChineseMedicine, vol.
28, no. 4, pp. 291–292, 2009.
[41] J. Z. Zhang, “Efficacy analysis on integrated traditional Chinese
and Western medicine in treating 64 cases of depression,”
Chinese Journal of Practical Nervous Diseases, vol. 15, no. 10, pp.
39–40, 2012 (Chinese).
[42] K. Cheng, H. Yan, and K. J. Duan, “Clinical observation
on the efficacy of self-invented Chinese medicine in treating
depression,” Clinical Journal of Traditional Chinese Medicine,
vol. 20, no. 4, pp. 375–376, 2008 (Chinese).
[43] L. J. Mao, Y. Lu, andW. X. Song, “Observation on the efficacy of
yushu pills in treating 70 cases of depression,” Chinese Journal
of Integrative Medicine on Cardio-cerebrovascular Disease, vol.
4, no. 12, pp. 1047–1048, 2006 (Chinese).
[44] L. R. Li, Z. X. Chen, and L. Kong, “Jieyu heji on 50 cases of
depression,” Guanming Journal of Chinese Medicine, vol. 25, no.
12, pp. 2206–2207, 2010 (Chinese).
[45] M. Zhang and W. Z. Xiao, “Clinical observation on Danzhi
Xiaoyao powder in treating depression in patients with dia-
betes,” Journal of Liaoning University of TCM, vol. 10, no. 2, pp.
108–109, 2008 (Chinese).
12 Evidence-Based Complementary and Alternative Medicine
[46] P. Zhou, L. Q. Chen, X. M. Peng et al., “Clinical observation
on banxia houpu decoction combining fluoxetine in treating
depressive adolescents,” Chinese Journal of Integrative Medicine
on Cardio-cerebrovascular Disease, vol. 9, no. 2, pp. 247–248,
2011 (Chinese).
[47] R. C. Wang, “Clinical observation on modified xiaoyao san in
treating depression,”Medical Journal of Chinese Peoples Health,
vol. 20, no. 13, pp. 1504–1505, 2008 (Chinese).
[48] R. X. Yang, Y. Dong, and D. M. Wang, “Clinical observation on
Shujiele Watang pills in treating depression,” Chinese Medicine
Focus, vol. 1, no. 5, pp. 16–17, 2002 (Chinese).
[49] S. Y. Liu, “Observation of chaihushugan powder plus psycholog-
ical nursing intervention therapy on acute poststroke depres-
sion,” Journal of Emergency in Traditional ChineseMedicine, vol.
8, no. 8, pp. 1205–1207, 2012 (Chinese).
[50] W. F. Long and Z. H. Dan, “Jieyu Yi Hao in treating 30 cases of
depression caused by dual deficiency of the heart and spleen,”
Journal of New Chinese Medicine, vol. 43, no. 3, pp. 38–39, 2010
(Chinese).
[51] W. X. Huang, Y. H. Yin, and J. J. Hu, “Chaihu Shugan powder
combining deanxit on 32 cases of post-stroke depression,”
Fujian Journal of Traditional Chinese Medicine, vol. 41, no. 5, pp.
21–22, 2010 (Chinese).
[52] X. Gao, “Xiaoyao powder combined with escitalopram oxalate
tablets in the treatment of Depression,” China Modern Doctor,
vol. 50, no. 1, pp. 66–70, 2012 (Chinese).
[53] Y. C. Ma, Z. X. Chen, W. D. Jin et al., “Preliminary observation
on treating depression in the integrative medicine,” Clinical
Journal of ChineseMedicine, vol. 3, no. 1, pp. 6–7, 2011 (Chinese).
[54] Y. F. Ma, “Study on modified xiaoyao san combining fluoxetine
in treating 80 cases of post-stroke,” Journal of Noah China Coal
Medical University, vol. 12, no. 2, pp. 187–188, 2010 (Chinese).
[55] Y. J. Li, H. C. Luo, and R. Q. Qian, “Effect of danzhi xiaoyao
san on depressive patients’ neuro -immune-endocrine system,”
Chinese Journal of Integrative Medicine, vol. 27, no. 3, pp. 197–
200, 2007 (Chinese).
[56] Y. K. Huang, J. Chen, and Y. Q. Huang, “Clinical observation on
the treatment efficacy of Xiayao pills on 62 cases of depression
caused by liver qi depression,” Fujian Journal of Traditional
Chinese Medicine, vol. 40, no. 5, pp. 3–4, 2009 (Chinese).
[57] Y. L. Liu and S. L. Dong, “Observation on the efficacy of
Danzhi Xiaoyao San in treating depression in patients with
hypertension,” Chinese Journal of Integrated Traditional and
Chinese Medicine, vol. 28, no. 3, pp. 280–281, 2008 (Chinese).
[58] Y. M. Guo, C. F. Liu, and J. J. Yang, “Chinese medicine on 38
cases of depression,” China’s Naturopathy, vol. 9, no. 10, pp. 56–
57, 2001 (Chinese).
[59] Y. M. Song, “Treating 30 cases of depression using the method
of Shugan Jieyu liqi,” Chinese Medicine Modern Education of
China, vol. 9, no. 16, pp. 7–8, 2011 (Chinese).
[60] Y. Wang and S. S. Liu, “Clinical observation on danzhi xiaoyao
san combining fluoxetine in treating depression,” Journal of
Community Medicine, vol. 5, no. 11, pp. 57–58, 2007 (Chinese).
[61] Y. Q. Jian, “Pattern-based integrated traditional Chinese and
Western medicine treatment on 30 cases of depression,” Liaon-
ing Journal of Traditional Chinese Medicine, vol. 28, p. 236, 2001
(Chinese).
[62] Y. X. Wang, Y. B. Gao, H. Zhou, Z. Guan, and X. Z. Shang,
“Qi-Yin nourishing method to treat diabetes with depression,”
World Journal of Traditional Chinese Medicine, vol. 5, no. 6, pp.
397–399, 2010 (Chinese).
[63] Z. Lian and Q. Wu, “Treatment efficacy analysis of chaihu
shugan powder combining fluoxetine in treating post-stroke
depression,”Guangming Journal of ChineseMedicine, vol. 24, no.
1, pp. 101–102, 2009 (Chinese).
[64] Z. X. Bao, Q. Tian, W. Zhou, W. Sun, and G. P. He, “Clinical
observation of influence of Zhuyang Shuxin recipe on TCM
syndrome of patients with depression with syndrome of liver
and kidney yang deficiency,” Chinese Archives of Traditional
Chinese Medicine, vol. 30, no. 10, pp. 116–118, 2012 (Chinese).
[65] Z. X. Chen, Y. C.Ma,W.D. Jin et al., “Clinical study on the treat-
ment of depressive patients caused by different TCM pattern
using integrated traditional Chinese and Western medicine,”
International Journal of Traditional Chinese Medicine, vol. 33,
no. 5, pp. 421–424, 2011 (Chinese).
[66] Q.-Q. Mao, S.-P. Ip, Y.-F. Xian, Z. Hu, and C.-T. Che, “Anti-
depressant-like effect of peony: a mini-review,” Pharmaceutical
Biology, vol. 50, no. 1, pp. 72–77, 2012.
[67] H.-X. Sun, “Haemolytic activities and adjuvant effect of Bupleu-
rum chinense saponins on the immune responses to ovalbumin
in mice,” Vaccine, vol. 24, no. 9, pp. 1324–1331, 2006.
[68] D. Xie, X. Jia, B. Cai, and L. Zhang, “Experimental study
on anti-inflammatory and analgesic effects of volatile oil of
Bupleurum chinense and B. scorzonerifolium,”Asian Journal of
Pharmaceutical and Clinical Research, vol. 15, pp. 108–110, 2007.
[69] Y. Yang, Chinese Medical Formulae, Beijing Shi: Ren min wei
sheng chu ban she, Beijing, China, 2001, (Chinese).
[70] W.-F. Yeung, K.-F. Chung,M.M.-K. Poon et al., “Prescription of
Chinese herbal medicine and selection of acupoints in pattern-
based traditional Chinese medicine treatment for insomnia: a
systematic review,” Evidence-based Complementary and Alter-
native Medicine, vol. 2012, Article ID 902578, 16 pages, 2012.
Submit your manuscripts at
http://www.hindawi.com
Stem Cells
International
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
MEDIATORS
INFLAMMATION
of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Behavioural 
Neurology
Endocrinology
International Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Disease Markers
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
BioMed 
Research International
Oncology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Oxidative Medicine and 
Cellular Longevity
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
PPAR Research
The Scientific 
World Journal
Hindawi Publishing Corporation 
http://www.hindawi.com Volume 2014
Immunology Research
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Journal of
Obesity
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
 Computational and  
Mathematical Methods 
in Medicine
Ophthalmology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Diabetes Research
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Research and Treatment
AIDS
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Gastroenterology 
Research and Practice
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Parkinson’s 
Disease
Evidence-Based 
Complementary and 
Alternative Medicine
Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com
